menu search

tracon pharmaceuticals announces participation at upcoming investor conferences

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- tracon Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical s...

September 5, 2023, 4:02 pm

tracon pharmaceuticals, inc. (tcon) q2 2023 earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q2 2023 Earnings Call August 14, 2023 4:30 PM ET Company Pa...

August 14, 2023, 6:50 pm

tracon to report second quarter 2023 financial results and provide corporate update on august 14, 2023

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- tracon Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical st...

August 2, 2023, 4:05 pm

tracon pharmaceuticals to present at the jefferies healthcare conference

SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) — tracon Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical s...

June 2, 2023, 12:00 pm

tracon pharmaceuticals, inc. (tcon) q1 2023 earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Co...

May 10, 2023, 10:18 pm

tracon pharmaceuticals announces arbitration award in dispute with i-mab

SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) — tracon Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical ...

April 25, 2023, 11:41 am

Why is tracon pharma (tcon) stock down 51% today?

tracon Pharmaceuticals (NASDAQ: TCON ) stock is falling on Tuesday following an update on a legal battl...

April 25, 2023, 9:11 am

tracon (tcon) moves to buy: rationale behind the upgrade

tracon (TCON) might move higher on growing optimism about its earnings prospects, which is reflected by...

March 14, 2023, 1:44 pm

tracon pharmaceuticals, inc. (tcon) q4 2022 earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET C...

March 8, 2023, 8:00 pm

Revisiting tracon pharmaceuticals

Today, we look back in on clinical stage developmental firm tracon Pharmaceuticals for the first time s...

November 30, 2022, 1:43 am

tracon pharmaceuticals doses first patient in drug trial to treat malignant tumours

tracon Pharmaceuticals Inc (NASDAQ:TCON) said it has dosed the first patient in a Phase 1/2 trial eval...

November 21, 2022, 8:41 am

tracon pharmaceuticals, inc. (tcon) q3 2022 earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ...

November 14, 2022, 10:43 pm

tracon pharmaceuticals ends 3q with $17m cash and equivalents to fund operations into mid-2023

tracon Pharmaceuticals Inc announced that it has ended its third-quarter 2022 with cash and equivalen...

November 14, 2022, 4:45 pm

tracon pharmaceuticals strikes $35m debt financing facility with runway growth capital

tracon Pharmaceuticals Inc (NASDAQ:TCON) has announced a $35 million non-dilutive long-term debt facili...

September 6, 2022, 8:46 am

tracon pharmaceuticals, inc. (tcon) ceo charles theuer on q2 2022 results - earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET...

August 10, 2022, 10:09 pm

tracon pharmaceuticals ends 2q with strong cash runway to support key trials

tracon Pharmaceuticals (NASDAQ:TCON) Inc rounded out the second quarter with a strong cash runway to c...

August 10, 2022, 5:04 pm

tracon pharmaceuticals says envasarc trial gets recommendation to proceed as planned

tracon Pharmaceuticals (NASDAQ:TCON) Inc announced that the Independent Data Monitoring Committee for t...

August 10, 2022, 9:33 am

tracon pharmaceuticals enrols 36th patient at envasarc trial triggering 4q interim efficacy analysis

tracon Pharmaceuticals (NASDAQ:TCON) Inc said an initial independent data monitoring committee (IDMC) i...

July 26, 2022, 9:03 am

tracon pharmaceuticals to present at the h.c. wainwright global investment conference

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- tracon Pharmaceuticals (Nasdaq: TCON), a clinical stage bio...

May 16, 2022, 8:05 am

tracon pharmaceuticals, inc. (tcon) ceo charles theuer on q1 2022 results - earnings call transcript

tracon Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Co...

May 11, 2022, 11:36 pm


Search within

Pages Search Results: